NASDAQ:JANX | Insider Transactions — Page 4 | Janux Therapeutics, Inc.

JANX Insider Transactions — Page 4

309 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 301–309; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Avalon BioVentures SPV I, L.P.TenPercentOwner2021-06-15Purchase629,411.0$17.0
RA Capital Healthcare Fund LPDirector,TenPercentOwner2021-06-15Purchase188,986.0$17.0
RA CAPITAL MANAGEMENT, L.P.Director,TenPercentOwner2021-06-15Purchase188,986.0$17.0
Kolchinsky PeterDirector,TenPercentOwner2021-06-15Purchase188,986.0$17.0
Shah Rajeev M.Director,TenPercentOwner2021-06-15Purchase188,986.0$17.0
RA Capital Healthcare Fund LPDirector,TenPercentOwner2021-06-15Purchase2,752,190.0$17.0
RA CAPITAL MANAGEMENT, L.P.Director,TenPercentOwner2021-06-15Purchase2,752,190.0$17.0
Kolchinsky PeterDirector,TenPercentOwner2021-06-15Purchase2,752,190.0$17.0
Shah Rajeev M.Director,TenPercentOwner2021-06-15Purchase2,752,190.0$17.0